Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Shinya Toyokuni. (2002) Iron and carcinogenesis: from Fenton reaction to target genes. Redox Report 7:4, pages 189-197.
Read now
Read now
Marco T. Núñez, Victoria Tapia, Shinya Toyokuni & Shigeru Okada. (2001) Iron-induced oxidative damage in colon carcinoma (caco-2) cells. Free Radical Research 34:1, pages 57-68.
Read now
Read now
J. Kaczynski, G. Hansson, G. Norkrans & S. Wallerstedt. (1991) Lack of Correlation Between Hepatitis B Virus Infection and the Increasing Incidence of Primary Liver Cancer in Sweden. Acta Oncologica 30:7, pages 811-813.
Read now
Read now
Gordon D. McLaren, W. Angus Muir, Robert W. Kellermeyer & Allan Jacobs. (1983) Iron Overload Disorders: Natural History, Pathogenesis, Diagnosis, and Therapy. CRC Critical Reviews in Clinical Laboratory Sciences 19:3, pages 205-266.
Read now
Read now
Articles from other publishers (34)
Chang-Kyu Oh & Yuseok Moon. (2019) Dietary and Sentinel Factors Leading to Hemochromatosis. Nutrients 11:5, pages 1047.
Crossref
Crossref
Nathan Jones, Joseph Ashmore, Sang Lee, John Richie, Philip Lazarus & Joshua Muscat. (2015) Association Studies of HFE C282Y and H63D Variants with Oral Cancer Risk and Iron Homeostasis Among Whites and Blacks. Cancers 7:4, pages 2386-2396.
Crossref
Crossref
Henryk DancygierClaus Niederau. 2010. Clinical Hepatology. Clinical Hepatology
1045
1070
.
Charronne F. Davis & M. Tevfik Dorak. 2010. Environmental Factors, Genes, and the Development of Human Cancers. Environmental Factors, Genes, and the Development of Human Cancers
445
475
.
Shinya Toyokuni. (2009) Role of iron in carcinogenesis: Cancer as a ferrotoxic disease. Cancer Science 100:1, pages 9-16.
Crossref
Crossref
A. Kalt, A. Wagner, S. Zeuzem, W. Tilgen & J. Reichrath. (2005) Generalisierte Hyperpigmentierung und Acanthosis nigricans maligna bei einem Patienten mit hereditärer Hämochromatose und MagenkarzinomGeneralized hyperpigmentation and malignant acanthosis nigricans in a patient with hereditary hemochromatosis and gastric cancer. Der Hautarzt 56:6, pages 581-585.
Crossref
Crossref
James C Barton, Luigi F Bertoli & Ronald T Acton. (2004) HFE C282Y and H63D in adults with malignancies in a community medical oncology practice. BMC Cancer 4:1.
Crossref
Crossref
Kris V. Kowdley. (2004) Iron, hemochromatosis, and hepatocellular carcinoma. Gastroenterology 127:5, pages S79-S86.
Crossref
Crossref
Maria Elmberg, Rolf Hultcrantz, Anders Ekbom, Lena Brandt, Sigvard Olsson, Rolf Olsson, Stefan Lindgren, Lars Lööf, Per Stål, Sven Wallerstedt, Sven Almer, Hanna Sandberg-Gertzén & Johan Askling. (2003) Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives. Gastroenterology 125:6, pages 1733-1741.
Crossref
Crossref
Shinya Toyokuni. 2003. Redox-Genome Interactions in Health and Disease. Redox-Genome Interactions in Health and Disease.
N. J. Shaheen, L. M. Silverman, T. Keku, L. B. Lawrence, E. M. Rohlfs, C. F. Martin, J. Galanko & R. S. Sandler. (2003) Association Between Hemochromatosis (HFE) Gene Mutation Carrier Status and the Risk of Colon Cancer. JNCI Journal of the National Cancer Institute 95:2, pages 154-159.
Crossref
Crossref
Graeme A Macdonald, Jabsar Tarish, Vicki Jl Whitehall, Sally J M, George D MellickRon L Buttenshaw, Anthony G JohnsonJoanne Young & Barbara A Leggett. (2001) No evidence of increased risk of colorectal cancer in individuals heterozygous for the Cys282Tyr haemochromatosis mutation. Journal of Gastroenterology and Hepatology 14:12, pages 1188-1191.
Crossref
Crossref
Marcelo Hermes-Lima, Eva Nagy, Prem Ponka & Herbert M Schulman. (1998) The iron chelator pyridoxal isonicotinoyl hydrazone (PIH) protects plasmid pUC-18 DNA against OH-mediated strand breaks. Free Radical Biology and Medicine 25:8, pages 875-880.
Crossref
Crossref
Shigeru Okada. (1998) Iron and carcinogenesis in laboratory animals and humans: A mechanistic consideration and a review of literature. International Journal of Clinical Oncology 3:4, pages 191-203.
Crossref
Crossref
Gürsel Soybir, Ferda Köksoy, Hülya Koyuncu, Orhan Yalçin, Hakki Köse & Cemalettin Topuzlu. (1998) Chemoprevention of DMBA-induced mammary gland carcinogenesis – preventive effects of free oxygen radical scavengers. Breast Cancer Research and Treatment 50:2, pages 193-199.
Crossref
Crossref
Mieko Kimura & Tomio Hirohata. 1997. Food Factors for Cancer Prevention. Food Factors for Cancer Prevention
389
395
.
David L. Witte, William H. Crosby, Corwin Q. Edwards, Virgil F. Fairbanks & Frank A. Mitros. (1996) Hereditary hemochromatosis. Clinica Chimica Acta 245:2, pages 139-200.
Crossref
Crossref
Shinya Toyokuni. (1996) Iron-induced carcinogenesis: The role of redox regulation. Free Radical Biology and Medicine 20:4, pages 553-566.
Crossref
Crossref
Ann W. Hsing, Joseph K. McLaughlin, Jorgcn H. Olsen, Lenc Mellemkjar, Sholom Wacholder & Joseph F. FraumeniJr.Jr.. (2006) Cancer risk following primary hemochromatosis: A population‐based cohort study in Denmark. International Journal of Cancer 60:2, pages 160-162.
Crossref
Crossref
C. Niederau, W. Stremmel & G.W.W. Strohmeyer. (1994) 7 Clinical spectrum and management of haemochromatosis. Baillière's Clinical Haematology 7:4, pages 881-901.
Crossref
Crossref
Claus Niederau, Georg Strohmeyer & Wolfgang Stremmel. 1994. Progress in Iron Research. Progress in Iron Research
293
302
.
Shinya Toyokuni & Jose-Luis Sagripanti. (1993) Induction of oxidative single- and double-strand breaks in DNA by ferric citrate. Free Radical Biology and Medicine 15:2, pages 117-123.
Crossref
Crossref
Hie-Won L. Hann, Mark W. Stahlhut, Raphael Rubin & Willis C. Maddrey. (1992) Antitumor effect of deferoxamine on human hepatocellular carcinoma growing in athymic nude mice. Cancer 70:8, pages 2051-2056.
Crossref
Crossref
Eugene D. Weinberg. (1992) Roles of iron in neoplasia. Biological Trace Element Research 34:2, pages 123-140.
Crossref
Crossref
Silvia Fargion, Clara Mandelli, Alberto Piperno, Bruno Cesana, Anna L. Fracanzani, Mirella Fraquelli, Paolo A. Bianchi, Gemino Fiorelli & Dario Conte. (1992) Surival and prognostic factors in 212 Italian patients with genetic hemochromatosis. Hepatology 15:4, pages 655-659.
Crossref
Crossref
Christopher F. Bryan, Stephen H. Leech, Prem Kumar, Richard Gaumer, Brian Bozelka & Jane Morgan. (1991) The Immune System in Hereditary Hemochromatosis: A Quantitative and Functional Assessment of the Cellular Arm. The American Journal of the Medical Sciences 301:1, pages 55-61.
Crossref
Crossref
Norman D. Grace. 1989. Current Perspectives in Hepatology. Current Perspectives in Hepatology
287
297
.
Georg Strohmeyer, Claus Niederau & Wolfgang Stremmel. (1988) Survival and Causes of Death in Hemochromatosis.. Annals of the New York Academy of Sciences 526:1 Hemochromatos, pages 245-257.
Crossref
Crossref
M.F. Good, L.W. Powell & J.W. Halliday. (1988) Iron status and cellular immune competence. Blood Reviews 2:1, pages 43-49.
Crossref
Crossref
Robin A. Bradbear, June W. Halliday, Mark L. Bassett, W. Graham Cooksley & Lawrie W. Powell. 1987. Neoplasms of the Liver. Neoplasms of the Liver
189
197
.
C. Niederau, W. Stremmel & G. Strohmeyer. 1987. Ergebnisse der Inneren Medizin und Kinderheilkunde/Advances in Internal Medicine and Pediatrics. Ergebnisse der Inneren Medizin und Kinderheilkunde/Advances in Internal Medicine and Pediatrics
117
148
.
Lawrie W. Powell. (1986) Hemochromatosis: Precirrhotic therapy restores normal life expectancy. Hepatology 6:6, pages 1423-1425.
Crossref
Crossref
Claus Niederau, Rudolf Fischer, Amnon Sonnenberg, Wolfgang Stremmel, Hans J. Trampisch & Georg Strohmeyer. (1985) Survival and Causes of Death in Cirrhotic and in Noncirrhotic Patients with Primary Hemochromatosis. New England Journal of Medicine 313:20, pages 1256-1262.
Crossref
Crossref
Raymond J. ShambergerRaymond J. Shamberger. 1984. Nutrition and Cancer. Nutrition and Cancer
195
262
.